Hop J W, Rinkel G J, Algra A, van Gijn J
Department of Neurology, University of Utrecht, The Netherlands.
J Neurosurg. 2001 Dec;95(6):957-63. doi: 10.3171/jns.2001.95.6.0957.
Although the case-fatality rate after subarachnoid hemorrhage (SAH) does not change considerably after the first 4 weeks, functional outcome and the quality of life (QOL) may. To assess the extent of changes in functional outcome and QOL after SAH, the authors conducted a follow-up study at 18 months in patients and caregivers who had participated in a previous study of QOL 4 months after SAH.
In a consecutive series of 98 patients admitted with SAH, 68 had survived until 4 months postbleed, at which time an initial outcome assessment had been performed in 64 of them. This series of 64 patients was contacted again at a median of 18 months after SAH. In all patients, functional outcome was assessed by means of the modified Rankin Scale (mRS). In 48 patients and 35 caregivers QOL was assessed using the SF-36, the Sickness Impact Profile (SIP), and a visual analog scale. The results were compared with the scores that had been obtained at 4 months after SAH. Thirty-two patients (50%) had improved at least one point on the mRS, in 23 patients functional outcome had remained unchanged, six patients had deteriorated one point on the mRS, and three had died. No major changes in the QOL of patients and caregivers could be found on the SIP, but on the SF-36 an improved QOL was detected in patients with better Rankin grades. On both instruments, the QOL at 18 months was still reduced compared with the reference population in all patients.
Functional outcome improves significantly between 4 months and 18 months post-SAH; studies on functional outcome after SAH can be compared only if outcome is assessed at the same time interval. The improved functional outcome seems to be accompanied by an improved QOL.
虽然蛛网膜下腔出血(SAH)后的病死率在最初4周后变化不大,但功能转归和生活质量(QOL)可能会改变。为了评估SAH后功能转归和QOL的变化程度,作者对参与过SAH后4个月QOL前期研究的患者及其照料者进行了一项为期18个月的随访研究。
在连续收治的98例SAH患者中,68例存活至出血后4个月,其中64例在此时进行了初始转归评估。在SAH后中位时间18个月时再次联系这64例患者。所有患者均采用改良Rankin量表(mRS)评估功能转归。48例患者和35例照料者采用SF-36、疾病影响量表(SIP)和视觉模拟量表评估QOL。将结果与SAH后4个月时获得的评分进行比较。32例患者(50%)的mRS至少改善了1分,23例患者的功能转归保持不变,6例患者的mRS恶化了1分,3例患者死亡。在SIP上未发现患者及其照料者的QOL有重大变化,但在SF-36上,Rankin分级较好的患者的QOL有所改善。在这两种量表上,所有患者18个月时的QOL与参照人群相比仍有所降低。
SAH后4个月至18个月之间功能转归显著改善;只有在相同时间间隔评估转归时,SAH后功能转归的研究才能进行比较。功能转归的改善似乎伴随着QOL的改善。